|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.10 SEK | +5.76% |
|
+11.31% | -15.49% |
| 07-20 | SynAct Pharma Draws SEK50 Million from New Financing Facility | MT |
| 07-20 | Synact Pharma secures access to financing of up to €9.0m | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 106M | - | - | - | - | - |
| 1T | |||||
| 613B | |||||
| 433B | |||||
| 350B | |||||
| 292B |
- Stock Market
- Stocks
- SYNACT Stock
- Charts SynAct Pharma AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
